{"disease":{"id":"acquired-hypogonadotropic-hypogonadism","name":"acquired hypogonadotropic hypogonadism"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02651688","title":"A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Repros Therapeutics Inc.","has_results":true},{"nct_id":"NCT04189133","title":"Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":32,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria di Modena","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}